Trial Profile
Phase II combination study of SB 9200 in patients with Hepatitis C Virus (HCV) Infection
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Inarigivir soproxil (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 29 Apr 2015 New trial record